Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist
Executive Summary
Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3
You may also be interested in...
Global Price Controls Cost Rx Industry $18-$27 Bil. A Year, Commerce Says
Global price controls cost pharmaceutical companies approximately $18 bil. to $27 bil. a year in lost revenue, the Commerce Department maintains in a Dec. 21 report to Congress entitled "Foreign Drug Price Controls: Their Effects on R&D, Innovation and Consumer Welfare.
Global Price Controls Cost Rx Industry $18-$27 Bil. A Year, Commerce Says
Global price controls cost pharmaceutical companies approximately $18 bil. to $27 bil. a year in lost revenue, the Commerce Department maintains in a Dec. 21 report to Congress entitled "Foreign Drug Price Controls: Their Effects on R&D, Innovation and Consumer Welfare.
House May Be Stopping Point For Rx Importation Bills, Hill Staffer Says
The House could be the last line of defense for blocking prescription drug importation legislation, rather than the Senate, a House subcommittee staffer said Nov. 17 at the Pharmaceutical Regulatory & Compliance Congress in Washington, D.C